AgelessRx, a digital longevity clinic based in Michigan, has announced the launch of Tadalafil Daily, a low-dose, prescription-based formulation of the FDA-approved drug traditionally used to treat erectile dysfunction and benign prostatic hyperplasia. The new offering is part of the company’s broader mission to improve healthspan through preventative therapies.
The company said that Tadalafil Daily may support cardiovascular and endothelial function, and has shown potential benefits in areas such as increased blood flow, inflammation modulation, and physical performance. While typically associated with sexual health, AgelessRx positions this formulation as a longevity therapy aimed at broader systemic benefits.
“The goal is to expand the scope of preventative tools we offer our patients,” said Dr. Sajad Zalzala, AgelessRx’s Co-Founder and Chief Medical Officer. “We’re guided by research that continues to suggest low-dose tadalafil may have healthspan-enhancing properties.”
AgelessRx claims that its Tadalafil Daily will be available through its existing telemedicine platform, where patients can consult with licensed providers and receive individualized treatment plans. The formulation is available in 2.5mg and 5mg dosages and includes free shipping and customer support.
This launch follows the company’s earlier rollouts of longevity-focused treatments including Metformin, NAD+ therapies, and Rapamycin. The company said it plans to continue expanding its prescription-based offerings aligned with emerging evidence in the longevity field.
